Can Iressa really cure lung cancer?

summary

After people suffer from lung cancer, a kind of medicine that they often need to take is IRESSA. Because lung cancer is a relatively difficult disease to cure, this paper makes a detailed analysis on whether Iressa can really cure lung cancer.

Can Iressa really cure lung cancer?

First: Iressa, commonly known as gefitinib. ZD1839 is a small molecule inhibitor of EGFR tyrosine kinase, which can be used for oral administration. ZD1839 was discovered in 1994. Subsequent studies have found that ZD1839 can inhibit the growth and survival of non-small cell lung cancer (NSCLC) and other tumors, including colorectal cancer, head and neck cancer, breast cancer cells and prostate cancer.

Second: according to clinical studies, Iressa has a higher efficacy in the treatment of eastern hemisphere people (mainly Asians), non-smokers, women, patients with alveolar cell carcinoma or adenocarcinoma.

Finally: in fact, in the analysis of the curative effect of Iressa, it also shows different effects in the treatment of different lung cancer. The curative effect of Iressa on lung squamous cell carcinoma is lower than that of adenocarcinoma and alveolar carcinoma. However, some patients with lung squamous cell carcinoma and other non-small cell lung cancer can get obvious curative effect after taking Iressa according to the actual situation of patients.

matters needing attention

After understanding whether Iressa can really cure lung cancer, patients should remember to stop breastfeeding if they are in lactation period.